China Botanic Pharmaceutical (CBP) Reports Q2 Earnings of $0.21; Reaffirms Outlook

China Botanic Pharmaceutical (NYSE: CBP) reported Q2 EPS of $0.21, versus $0.19 reported last year. Revenue for the quarter came in at $23 million, versus $18.9 million reported last year.

China Botanic Pharmaceutical reaffirmed FY2012 guidance.

For earnings history and earnings-related data on China Botanic Pharmaceutical (CBP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Hour Loop, Inc. (HOUR) Reports Q2 EPS of $0.03
• Alabama Power Co. 5.875% Sr. Notes Series 2007b (ALM) Tops Q2 EPS by 62c